DK183882A - Fremgangsmaade til fremstilling af phen(alk)oxy-substituerede oxirancarboxylsyrer - Google Patents

Fremgangsmaade til fremstilling af phen(alk)oxy-substituerede oxirancarboxylsyrer Download PDF

Info

Publication number
DK183882A
DK183882A DK183882A DK183882A DK183882A DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A
Authority
DK
Denmark
Prior art keywords
denotes
phen
alk
oxy
integer
Prior art date
Application number
DK183882A
Other languages
English (en)
Other versions
DK171890B1 (da
Inventor
Klaus Eistetter
Gerhard Ludwig
Horst Wolf
Erich Rapp
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of DK183882A publication Critical patent/DK183882A/da
Application granted granted Critical
Publication of DK171890B1 publication Critical patent/DK171890B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

Figure DK183882AD00021
og eventuelt påfølgende hydrolyse, saltdannelse eller omesterificering.
Forbindelserne I har hypoglycæmisk virkning på varmblodede dyr, herunder mennesker.
DK183882A 1980-08-25 1982-04-23 Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden DK171890B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH639780 1980-08-25
CH152681 1981-03-06
CH152681 1981-03-06
PCT/EP1981/000136 WO1982000643A1 (en) 1980-08-25 1981-08-24 Substituted oxiranecarbonic acids,preparation and pharmaceutical utilisation thereof
EP8100136 1981-08-24

Publications (2)

Publication Number Publication Date
DK183882A true DK183882A (da) 1982-04-23
DK171890B1 DK171890B1 (da) 1997-08-04

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183882A DK171890B1 (da) 1980-08-25 1982-04-23 Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden

Country Status (16)

Country Link
US (1) US4337267A (da)
EP (1) EP0046590B1 (da)
JP (1) JPS6059914B2 (da)
AU (1) AU549447B2 (da)
CA (1) CA1167050A (da)
DE (1) DE3170608D1 (da)
DK (1) DK171890B1 (da)
ES (1) ES504922A0 (da)
GR (1) GR75741B (da)
IE (1) IE51534B1 (da)
IL (1) IL63627A (da)
NZ (1) NZ198136A (da)
PH (1) PH21847A (da)
PT (1) PT73563B (da)
WO (1) WO1982000643A1 (da)
YU (1) YU206681A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231367B1 (de) * 1985-08-02 1991-07-24 Wolf, Horst P.O., Dr. Verwendung von oxirancarbonsäuren zur behandlung der hyperlipämie
EP0283168A3 (en) * 1987-03-16 1989-06-14 American Home Products Corporation Fluorooxirane carboxylates
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
JP2000513373A (ja) * 1996-07-02 2000-10-10 ジュウ，サング，スプ オキシランカルボキシル酸誘導体及びその製造方法
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) * 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
ES2400683T3 (es) * 2001-09-26 2013-04-11 Emisphere Technologies, Inc. Método de preparación de ácidos fenoi-alcanoicos y sales de los mismos mediante un producto intermedio de dicarboxilato
CN1964630A (zh) * 2003-02-13 2007-05-16 耶希瓦大学艾伯塔·爱恩斯坦医学院 通过控制下丘脑的长链脂肪酰基－辅酶A(LC－CoA)的水平来调控食物摄取和葡萄糖产生
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
US20090012067A1 (en) * 2005-02-14 2009-01-08 Luciano Rossetti Modulation of Hypothalamic Atp-Sensitive Potassium Channels
CA2766282C (en) * 2008-06-27 2021-03-02 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
MX389242B (es) 2015-06-15 2025-03-20 Nmd Pharma As Compuestos para su uso en el tratamiento de trastornos neuromusculares
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US12440477B2 (en) 2017-12-14 2025-10-14 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551078A (en) * 1975-09-22 1979-08-22 Mcneilab Inc Alkyl-substituted glycidates and thioglycidates
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
DE3032669A1 (de) * 1979-09-07 1981-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
IL63627A (en) 1984-11-30
DE3170608D1 (en) 1985-06-27
IL63627A0 (en) 1981-11-30
JPS6059914B2 (ja) 1985-12-27
JPS57501233A (da) 1982-07-15
PT73563A (en) 1981-09-01
AU549447B2 (en) 1986-01-30
EP0046590A3 (en) 1982-04-07
ES8300730A1 (es) 1982-11-16
EP0046590B1 (de) 1985-05-22
YU206681A (en) 1983-10-31
DK171890B1 (da) 1997-08-04
GR75741B (da) 1984-08-02
IE811931L (en) 1982-02-25
ES504922A0 (es) 1982-11-16
US4337267A (en) 1982-06-29
PH21847A (en) 1988-03-17
PT73563B (en) 1983-07-14
WO1982000643A1 (en) 1982-03-04
NZ198136A (en) 1983-12-16
AU7447581A (en) 1982-03-04
EP0046590A2 (de) 1982-03-03
IE51534B1 (en) 1987-01-07
CA1167050A (en) 1984-05-08

Similar Documents

Publication Publication Date Title
DK183882A (da) Fremgangsmaade til fremstilling af phen(alk)oxy-substituerede oxirancarboxylsyrer
ATE49195T1 (de) Herstellung von fibraten.
KR850003393A (ko) 1-벤질-아미노알킬-피롤리디논의 제조방법
ES470878A1 (es) Procedimiento para la aclaracion optica de materiales orga- nicos
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
JPS5570841A (en) Forming method of dye image
PT71773B (de) Verfahren zur herstellung von substituierten oxirancarbonsauren
ES503989A0 (es) Procedimiento para la obtencion de un producto de poliadi- cion-policondensacion que lleva grupos de nitrogeno basico
KR830008987A (ko) 니트로아닐린의 제조방법
KR890012991A (ko) 광학활성을 갖는 4-옥소-1-벤조피란-2-카르복시산 유도체 및 중간체의 제법
DK552682A (da) Fremgangsmaade til fremstilling af hydroxybenzylaminobenzener
KR840005434A (ko) 잡초류 억제용 신화합물
HUP9800869A1 (hu) Eljárás klór-ketoaminok előállítására karbamátok alkalmazásával
KR850003407A (ko) 유기인산 에스테르 유도체의 제조방법
DK179991A (da) Fremgangsmaade til fremstilling af 7-amino-3-chlor-3-cephem-4-carboxylsyreestere
RU95118432A (ru) Способ получения замещенных или незамещенных 1,4-дигидро-4-оксо-2- или 3-хинолинкарбоновых кислот
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
JPS54121126A (en) Dye image formation process for silver halide photographic material
ATE40117T1 (de) O-substituierte 3-oxypyridiniumsalze, verfahren zu ihrer herstellung und ihre verwendung als fungizide fuer den pflanzenschutz.
KR830005255A (ko) N-포스포노메틸글리시노니트릴 디아릴 에스테르의 퍼플루오로아미드의 제조방법
KR870006014A (ko) 피리미딜멀캅토-아실아닐리드의 제조방법
KR830003487A (ko) 벤조디아제핀 유도체의 제조방법
DE3677270D1 (de) Chinolin-8-carbonsaeureazolide, ein verfahren zu ihrer herstellung und ihre verwendung als herbizide.
DE68902971D1 (de) (ethylenedioxo-3,3 zyclohexyl)-4 aketophenon und derivate davon, verfahren zu deren herstellung und verwendung dieser verbindungen.
KR840005086A (ko) N-치환된-3.4.5.6-테트라하이드로프탈람 산유도체의 제조방법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
ARF Application refused